IDH2 and astrocytoma (excluding glioblastoma): Our work is an extension of previous studies as we used a GAN-based algorithm to increase our sample size and used a large number of machine learning classifiers (n = 18) to build a reliable prediction model in distinguishing IDH-mutant grade 4 astrocytomas and IDH-wild-type GBMs.